Abstract
Introduction
Today, liver transplantation is an established and successful procedure that represents the only causal and curative therapy for many liver diseases that lead to liver cirrhosis and consecutive liver failure in end-stage disease [1] . Despite its therapeutic potential it remains an unspecific approach that is limited by donor organ shortage [2] and the need for a life-long immunosuppressive therapy with its specific risks [3] . According [4] . This situation makes the search for alternatives to whole organ transplantation an important topic in current transplantation research.
Extracorporeal systems seem to be suitable for acute intervention in cases of acute liver failure (ALF) or intoxication, and may serve as a bridge to liver transplantation or organ recovery [5] . However, the long-term application of this concept is problematic due to technical limitations, high costs and the necessity of an intensive care unit setting.
Many liver diseases with primary intact liver function and organ architecture require only the correction or replacement of a small sector of the complex liver function that may in future be accomplished by gene therapy [6] . The transplantation of a hepatocyte mass equivalent to 10% of the patients' liver would be sufficient to normalize the metabolic situation in many enzyme deficiencies [7] . [54] . The system uses a hollow fibre bioreactor loaded with porcine hepatocytes.
For this purpose intracorporeal systems based on the transplantation of isolated liver cells are desirable. Cell transplantation has some advantages over organ transplantation: one donor organ could be used for many candidates. Because this is a much lesser invasive technique it is associated with a lower mortality and morbidity. Cell transplantation is also thought to be less immunogenic because transplanted allogenic cells could be immunomodulated prior to implantation or even autologous cells might be utilized following in vitro modification. Cell transplantation might be an option for patients with metabolic diseases because the complete organ does not need to be replaced and the deficient metabolic function could be replaced or at least supported by only a small portion of hepatocytes.

Development of cell isolation and primary culture for hepatocytes
Development of matrix-based hepatocyte transplantation
Over the last years, the injection of liver cell suspensions into anatomic structures such as the spleen [55] , the kidney capsule [56] or the peritoneal cavity [57] has been performed in different animal models. Especially, the intraportal hepatocyte injection has been reported to be successful in animal models of metabolic deficiencies [58] . Recently, intraportal hepatocyte injection has been successfully applied on patients with the Crigler-Najjar syndrome type 1 [59] . However, portal hypertension, portal vein thrombosis and pulmonary embolism remain problematic when larger cell numbers are transplanted [60, 61] .
Function and differentiation of liver cells are influenced by the three-dimensional organ architecture [62] . This concept led to combine cell transplantation with the application of three-dimensional, highly porous polymeric matrices as a concept of tissue engineering [63] (Fig. 2) [66] is also conceivable [67] . Heterotopic hepatocyte transplantation in matrices has been demonstrated in long-term studies [68] (Fig. 3) . Nevertheless, initial engraftment rates are suboptimal. In theory, the metabolic situation in patients with hepatic failure or other liver diseases may provide a hepatotrophic stimulus for hepatocytes in heterotopic locations per se.
. It has several advantages when compared to the injection of cell suspensions into solid organs (Table 2). The matrices provide sufficient volume for the transplantation of cell numbers up to whole organ equivalents [64]. Transplantation efficiency could be improved by optimizing shape and composition of the matrices as well as by attaching growth factors and ECMs to the polymeric scaffold [23, 65]. Cell transplantation into polymeric matrices is, in contrast to cell injection into anatomic structures, a reversible procedure because the cell matrix constructs may be removed if so desired. In the future, this concept may even allow the construction of preservable, implantable liver support devices that are available without restrictions. The use of three-dimensional matrices as a carrier for the transplantation of genetically altered cells
Fig. 2 Rat hepatocytes seeded on a three-dimensional polymeric matrix form a three-dimensional tissue in vitro after 3 days in culture.
However, such hepatotrophic effects could not be observed in animal models of metabolic enzyme deficiencies [69] [70] , but the need for vascular surgery combined with the procedure-specific side effects [71] may reduce its applicability in humans. Selective segmental liver transplantation experiments by Starzl et al. [72] revealed that the majority of the hepatotrophic factors in the portal venous blood originate from the pancreatic circulation. Therefore, pancreatic islet co-transplantation seems to be an alternative for the stimulation of hepatocytes in polymeric matrices [73] . Co [75] [76] [77] [78] [79] . In addition, recent data showed the possibility of creating a nanostructure in a capillary pattern by micro-electromechanical system (MEMS) [80] . In such a system a poly-glycol acid film was seeded with human umbilical vascular endothelial cells [81] . [66, 67] Co-transplantation of different cell types Increased hepatocyte survival and proliferation [73, 74] Long-term data after hepatocyte transplantation [68] Correction of vitamin C deficiency ODS rat [64] ODS 
, which are considered the most important future indication for intracorporeal liver support devices. Because optimal transplantation efficiency is a prerequisite for any future clinical application, the improvement of engraftment and the continuous long-term stimulation of hepatocytes in the polymeric matrices are of great interest. Portocaval shunt operation in the recipient is a standard procedure for experimental long-term stimulation of hepatocytes in heterotopic sites
